Braingaze

Braingaze

Private
LondonHealthcare & Life Scienceshttps://www.braingaze.com/

Last Round

Seed

Mar 6, 2024

Total Funding Raised

$2.37M

Company Overview

Braingaze is a healthtech company that provides objective, clinically validated tools for the diagnosis, treatment, and monitoring of ADHD and other neurodevelopmental conditions using eye-movement biomarker analysis and AI.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

ADHD diagnosiseye-tracking biomarkersdigital diagnosticsneurotechdigital therapeuticsAI medical diagnosisgamified therapyclinical decision supporteye tracking technologyobjective diagnosismental health techdigital biomarkersautism diagnosisneurodevelopmental disordersgaze-controlled games

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Braingaze Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Braingaze Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMar 6, 2024
GrantAug 15, 2019
CrowdfundingJun 3, 2016
Pre SeedJul 23, 2014

Key People

Founding team and executive leadership

Hans Supèr

Co-Founder & CTO

Founding Team

Braingaze Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 184% MoM.

  • Oct 28, 2024

    Monthly visitors grew 98% MoM.

Braingaze Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Braingaze Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Braingaze's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range11
Year Founded2013
Last FundingMar 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.